Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

CD18 is redundant for the response to multiple vaccines: A case study.

Assing K, Nielsen C, Hansen HT, Jakobsen MA, Skogstrand K, Brasch-Andersen C, Hartling UB, Fisker N.

Pediatr Allergy Immunol. 2019 Feb;30(1):136-139. doi: 10.1111/pai.12989. Epub 2018 Nov 13. No abstract available.

PMID:
30312521
2.

Sinogenic intracranial complications: is adalimumab a culprit?

Kofoed MS, Fisker N, Christensen AE, Kjeldsen AD.

BMJ Case Rep. 2018 Jan 17;2018. pii: bcr-2017-221449. doi: 10.1136/bcr-2017-221449.

PMID:
29348274
3.

Successful management of transfusion-dependent congenital dyserythropoietic anemia type 1b with interferon alfa-2a.

Rathe M, Møller MB, Greisen PW, Fisker N.

Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26866. Epub 2017 Oct 19.

PMID:
29049846
4.

Health-related quality of life in Danish children with hereditary angioedema.

Aabom A, Nguyen D, Fisker N, Bygum A.

Allergy Asthma Proc. 2017 Nov 1;38(6):440-446. doi: 10.2500/aap.2017.38.4093.

PMID:
29046193
5.

The ClpXP protease is dispensable for degradation of unfolded proteins in Staphylococcus aureus.

Stahlhut SG, Alqarzaee AA, Jensen C, Fisker NS, Pereira AR, Pinho MG, Thomas VC, Frees D.

Sci Rep. 2017 Sep 18;7(1):11739. doi: 10.1038/s41598-017-12122-y.

6.

Association Between Mode of Delivery and Risk of Infection in Early Childhood: A Cohort Study.

Christensen N, Søndergaard J, Christesen HT, Fisker N, Husby S.

Pediatr Infect Dis J. 2018 Apr;37(4):316-323. doi: 10.1097/INF.0000000000001778.

PMID:
28885459
7.

Clinical characteristics and real-life diagnostic approaches in all Danish children with hereditary angioedema.

Aabom A, Andersen KE, Fagerberg C, Fisker N, Jakobsen MA, Bygum A.

Orphanet J Rare Dis. 2017 Mar 16;12(1):55. doi: 10.1186/s13023-017-0604-6.

8.

From the Cover: The Minipig is a Suitable Non-Rodent Model in the Safety Assessment of Single Stranded Oligonucleotides.

Braendli-Baiocco A, Festag M, Dumong Erichsen K, Persson R, Mihatsch MJ, Fisker N, Funk J, Mohr S, Constien R, Ploix C, Brady K, Berrera M, Altmann B, Lenz B, Albassam M, Schmitt G, Weiser T, Schuler F, Singer T, Tessier Y.

Toxicol Sci. 2017 May 1;157(1):112-128. doi: 10.1093/toxsci/kfx025.

9.

Infant Respiratory Tract Infections or Wheeze and Maternal Vitamin D in Pregnancy: A Systematic Review.

Christensen N, Søndergaard J, Fisker N, Christesen HT.

Pediatr Infect Dis J. 2017 Apr;36(4):384-391. doi: 10.1097/INF.0000000000001452. Review.

PMID:
27977549
10.

Eczema Coxsackium Caused by Coxsackievirus A6.

Horsten HH, Fisker N, Bygum A.

Pediatr Dermatol. 2016 May;33(3):e230-1. doi: 10.1111/pde.12874. Epub 2016 Apr 18.

PMID:
27086897
11.

A novel mechanism for NETosis provides antimicrobial defense at the oral mucosa.

Mohanty T, Sjögren J, Kahn F, Abu-Humaidan AH, Fisker N, Assing K, Mörgelin M, Bengtsson AA, Borregaard N, Sørensen OE.

Blood. 2015 Oct 29;126(18):2128-37. doi: 10.1182/blood-2015-04-641142. Epub 2015 Aug 4.

PMID:
26243777
12.

Infantile hemophagocytic lymphohistiocytosis in a case of chediak-higashi syndrome caused by a mutation in the LYST/CHS1 gene presenting with delayed umbilical cord detachment and diarrhea.

Nielsen C, Agergaard CN, Jakobsen MA, Møller MB, Fisker N, Barington T.

J Pediatr Hematol Oncol. 2015 Mar;37(2):e73-9. doi: 10.1097/MPH.0000000000000300.

PMID:
25551669
13.

Antiviral treatment of a boy with EBV-associated hydroa vacciniforme.

Pahlow Mose A, Fisker N, Clemmensen O, Bygum A.

BMJ Case Rep. 2014 Nov 24;2014. pii: bcr2014206488. doi: 10.1136/bcr-2014-206488.

14.

Caesarean section and hospitalization for respiratory syncytial virus infection: a population-based study.

Kristensen K, Fisker N, Haerskjold A, Ravn H, Simões EA, Stensballe L.

Pediatr Infect Dis J. 2015 Feb;34(2):145-8. doi: 10.1097/INF.0000000000000552.

PMID:
25232778
15.

Immunodeficiency associated with a nonsense mutation of IKBKB.

Nielsen C, Jakobsen MA, Larsen MJ, Müller AC, Hansen S, Lillevang ST, Fisker N, Barington T.

J Clin Immunol. 2014 Nov;34(8):916-21. doi: 10.1007/s10875-014-0097-1. Epub 2014 Sep 14.

PMID:
25216719
16.

CD4+ CD31+ recent thymic emigrants in CHD7 haploinsufficiency (CHARGE syndrome): a case.

Assing K, Nielsen C, Kirchhoff M, Madsen HO, Ryder LP, Fisker N.

Hum Immunol. 2013 Sep;74(9):1047-50. doi: 10.1016/j.humimm.2013.06.002. Epub 2013 Jun 7.

PMID:
23747993
17.

Hospitalisation with otitis media in early childhood and cognitive function in young adult life: a prevalence study among Danish conscripts.

Mortensen M, Nielsen RB, Fisker N, Nørgaard M.

BMC Pediatr. 2013 Jan 15;13:8. doi: 10.1186/1471-2431-13-8.

18.

Genetical analysis of all Danish patients diagnosed with chronic granulomatous disease.

Jakobsen MA, Katzenstein TL, Valerius NH, Roos D, Fisker N, Mogensen TH, Jensen PØ, Barington T.

Scand J Immunol. 2012 Nov;76(5):505-11. doi: 10.1111/j.1365-3083.2012.02771.x.

19.

PCSK9 LNA antisense oligonucleotides induce sustained reduction of LDL cholesterol in nonhuman primates.

Lindholm MW, Elmén J, Fisker N, Hansen HF, Persson R, Møller MR, Rosenbohm C, Ørum H, Straarup EM, Koch T.

Mol Ther. 2012 Feb;20(2):376-81. doi: 10.1038/mt.2011.260. Epub 2011 Nov 22.

20.

The burden of rotavirus disease in Denmark 2009-2010.

Fischer TK, Rungoe C, Jensen CS, Breindahl M, Jørgensen TR, Nielsen JP, Jensen L, Malon M, Brændholt V, Fisker N, Hjelt K.

Pediatr Infect Dis J. 2011 Jul;30(7):e126-9. doi: 10.1097/INF.0b013e3182145277.

PMID:
21386748
21.

Sphingosine kinase 1 is a relevant molecular target in gastric cancer.

Fuereder T, Hoeflmayer D, Jaeger-Lansky A, Rasin-Streden D, Strommer S, Fisker N, Hansen BJ, Crevenna R, Wacheck V.

Anticancer Drugs. 2011 Mar;22(3):245-52.

PMID:
21360847
22.

Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates.

Straarup EM, Fisker N, Hedtjärn M, Lindholm MW, Rosenbohm C, Aarup V, Hansen HF, Ørum H, Hansen JB, Koch T.

Nucleic Acids Res. 2010 Nov;38(20):7100-11. doi: 10.1093/nar/gkq457. Epub 2010 Jul 8.

23.

A locked nucleic acid antisense oligonucleotide (LNA) silences PCSK9 and enhances LDLR expression in vitro and in vivo.

Gupta N, Fisker N, Asselin MC, Lindholm M, Rosenbohm C, Ørum H, Elmén J, Seidah NG, Straarup EM.

PLoS One. 2010 May 17;5(5):e10682. doi: 10.1371/journal.pone.0010682.

24.

Risk factors for respiratory syncytial virus hospitalisation in children with heart disease.

Kristensen K, Stensballe LG, Bjerre J, Roth D, Fisker N, Kongstad T, Svendsen AL, Nielsen BW.

Arch Dis Child. 2009 Oct;94(10):785-9. doi: 10.1136/adc.2008.143057. Epub 2009 Jun 18.

PMID:
19541682
25.

SPC3042: a proapoptotic survivin inhibitor.

Hansen JB, Fisker N, Westergaard M, Kjaerulff LS, Hansen HF, Thrue CA, Rosenbohm C, Wissenbach M, Orum H, Koch T.

Mol Cancer Ther. 2008 Sep;7(9):2736-45. doi: 10.1158/1535-7163.MCT-08-0161.

26.

[Prevention of vertical transmission of HIV in Denmark].

Rasmussen MB, Rasmussen JB, Nielsen VR, Herlin T, Fisker N, Hornstrup MK, Vinter H, Olofsson M, Weis NM.

Ugeskr Laeger. 2008 Aug 18;170(34):2567-70. Danish.

PMID:
18761841
27.

Lack of nonfunctional B-cell receptor rearrangements in a patient with normal B cell numbers despite partial RAG1 deficiency and atypical SCID/Omenn syndrome.

Ohm-Laursen L, Nielsen C, Fisker N, Lillevang ST, Barington T.

J Clin Immunol. 2008 Sep;28(5):588-92. doi: 10.1007/s10875-008-9210-7. Epub 2008 Jul 1.

PMID:
18592361
28.

Survivin mRNA antagonists using locked nucleic acid, potential for molecular cancer therapy.

Fisker N, Westergaard M, Hansen HF, Hansen JB.

Nucleosides Nucleotides Nucleic Acids. 2007;26(10-12):1427-30.

PMID:
18066798
29.

Long-term effectiveness of highly active antiretroviral therapy (HAART) in perinatally HIV-infected children in Denmark.

Bracher L, Valerius NH, Rosenfeldt V, Herlin T, Fisker N, Nielsen H, Obel N.

Scand J Infect Dis. 2007;39(9):799-804.

PMID:
17701719
30.

No serological evidence for rickettsial diseases among Danish elite orienteerers.

Schiellerup P, Dyhr T, Rolain JM, Christensen M, Damsgaard R, Fisker N, Andersen NF, Raoult D, Krogfelt KA.

Ann N Y Acad Sci. 2006 Oct;1078:150-3.

PMID:
17114697
31.

Identifying a hepatitis B outbreak by molecular surveillance: a case study.

Fisker N, Carlsen NL, Kolmos HJ, Tønning-Sørensen L, Høst A, Christensen PB.

BMJ. 2006 Feb 11;332(7537):343-5. No abstract available.

32.

The possibility of discriminating within the Bacillus cereus group using gyrB sequencing and PCR-RFLP.

Jensen GB, Fisker N, Sparsø T, Andrup L.

Int J Food Microbiol. 2005 Sep 25;104(1):113-20.

PMID:
16005534
33.

Low seroprevalence of bartonella species in danish elite orienteers.

Schiellerup P, Dyhr T, Rolain JM, Christensen M, Damsgaard R, Ethelberg S, Fisker N, Frost Andersen N, Raoult D, Krogfelt KA.

Scand J Infect Dis. 2004;36(8):604-6.

PMID:
15370673
34.

Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule.

Christensen PB, Fisker N, Krarup HB, Liebert E, Jaroslavtsev N, Christensen K, Georgsen J.

Vaccine. 2004 Sep 28;22(29-30):3897-901.

PMID:
15364437
35.

Molecular epidemiology of hepatitis B virus infections in Denmark.

Fisker N, Pedersen C, Lange M, Nguyen NT, Nguyen KT, Georgsen J, Christensen PB.

J Clin Virol. 2004 Sep;31(1):46-52.

PMID:
15288613
36.

Blood borne viral infections among Danish health care workers--frequent blood exposure but low prevalence of infection.

Fisker N, Mygind LH, Krarup HB, Licht D, Georgsen J, Christensen PB.

Eur J Epidemiol. 2004;19(1):61-7.

PMID:
15012024
37.

Clinical review of nontyphoid Salmonella infections from 1991 to 1999 in a Danish county.

Fisker N, Vinding K, Mølbak K, Hornstrup MK.

Clin Infect Dis. 2003 Aug 15;37(4):e47-52. Epub 2003 Jul 29.

PMID:
12905152
38.

GB virus C epidemiology in Denmark: different routes of transmission in children and low- and high-risk adults.

Christensen PB, Fisker N, Mygind LH, Krarup HB, Wedderkopp N, Varming K, Georgsen J.

J Med Virol. 2003 May;70(1):156-62.

PMID:
12629658
39.

Low hepatitis B prevalence among pre-school children in Denmark: saliva anti-HBc screening in day care centres.

Fisker N, Georgsen J, Stolborg T, Khalil MR, Christensen PB.

J Med Virol. 2002 Dec;68(4):500-4.

PMID:
12376957
40.

[Artificial respiration in patients with acute severe asthma. Mode of ventilation and survival].

Toft P, Fisker NJ, Andersen PK, Tønnesen EK.

Ugeskr Laeger. 1994 Dec 19;156(51):7687-92. Danish.

PMID:
7839534
41.

[Death after earlier deliberate self-poisoning. A 10-year material from an intensive care unit].

Fisker NJ, Andersen PK.

Ugeskr Laeger. 1993 Jun 14;155(24):1857-61. Danish.

PMID:
8317043
42.

[Proved self-poisoning. A 10-year case load from an intensive care unit].

Fisker NJ, Garcia RS, Andersen PK.

Ugeskr Laeger. 1991 Mar 18;153(12):840-4. Danish.

PMID:
2014568
43.

Acute excision or exposure treatment? Final results of a three-year randomized controlled clinical trial.

Sørensen B, Fisker NP, Steensen JP, Kalaja E.

Scand J Plast Reconstr Surg. 1984;18(1):87-93.

PMID:
6377487
44.

Acute excision or exposure treatment?

Sørensen B, Pedersen EK, Fisker NP, Steensen JP.

Acta Chir Plast. 1981;23(2):67-73. No abstract available.

PMID:
6167093

Supplemental Content

Loading ...
Support Center